Rowland Charles A Jr - Insider Non-Derivative Transactions at Viking Therapeutics, Inc. (VKTX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on May 16, 2023, Rowland Charles A Jr's relationship to Viking Therapeutics, Inc. (VKTX) is Director, and currently has 70,000 shares of Common Stock, par value $0.00001 per share.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other VKTX insiders.
Data Source: SEC.
Rowland Charles A Jr - Insider Non-Derivative Transactions at VKTX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| May 17, 2023 | Sell -- (Common Stock, par value $0.00001 per share) | 40000 | 25 | 30000 |
| May 17, 2023 | M -- (Common Stock, par value $0.00001 per share) | 40000 | 1.08 | 70000 |